Publisher erratum to “Fenofibrate-promoted hepatomegaly and liver regeneration are PPARα-dependent and partially related to the YAP pathway” [Acta Pharmaceutica Sinica B 14 (2024) 2992–3008]
Saved in:
| Main Authors: | Shicheng Fan, Yue Gao, Pengfei Zhao, Guomin Xie, Yanying Zhou, Xiao Yang, Xuan Li, Shuaishuai Zhang, Frank J. Gonzalez, Aijuan Qu, Min Huang, Huichang Bi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Acta Pharmaceutica Sinica B |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383525002692 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PPARα regulates YAP protein levels and activity by affecting its ubiquitination modification
by: Wenhong Zhou, et al.
Published: (2025-02-01) -
HMGB1 Is Involved in the Protective Effect of the PPARα Agonist Fenofibrate against Cardiac Hypertrophy
by: Zhankui Jia, et al.
Published: (2014-01-01) -
Nosological aspects of hepatomegaly and splenomegaly at pediatric age
by: M. M. Kotovich, et al.
Published: (2016-08-01) -
Liver damage and hepatomegaly in COVID-19 patients
by: Pınar Yürük Atasoy, et al.
Published: (2023-09-01) -
Fenofibrate Ameliorates Hepatic Ischemia/Reperfusion Injury in Mice: Involvements of Apoptosis, Autophagy, and PPAR-α Activation
by: Jie Zhang, et al.
Published: (2021-01-01)